Isosorbide was previously available in an oral formulation for the reduction of intraocular pressure. It was approved by the FDA in 1980, but has since been discontinued. Currently, isosorbide is an organic nitrate currently available in the isosorbide mononitrate and isosorbide dinitrate forms, and is used for the prevention of angina. Refer to these drug entries for more information.
Isosorbide was previously indicated for temporary reduction of intraocular pressure and used to interrupt an acute glaucoma attack, however, this is not a currently approved indication. Refer to isosorbide mononitrate and isosorbide dinitrate drug entries for more isosorbide indications.
Algazeerah, Giza, Egypt
Xijing Hoapital, Xi'an, Shaanxi, China
Lanzhou University Second Hospital, Lanzhou, Gansu, China
Xi'an Central Hospital, Xi'an, Shaanxi, China
Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China
Danish Headache Center, Glostrup, Region H, Denmark
Danish Headache Center, Glostrup, Region H, Denmark
Department of Obs & Gyn,Faculty of Medicine, Ain shams University., Cairo, Egypt
Royal Infirmary, Edinburgh, Lothian, United Kingdom
Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany
Medizinische Einrichtungen der Universität Bonn, Bonn, Nordrhein-Westfalen, Germany
SocraTec R&D GmbH, Erfurt, Thüringen, Germany
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.